Sharpe ratio
1.04Return earned for the risk taken.
Good
Good risk-adjusted returns. The fund has delivered strong returns for its level of risk.
+17.49%1Y Absolute Return
-0.19%1D
Loading NAV history…
Past performance is not an indicator of future returns.
Returns calculator comparison
Compare an illustrative investment outcome across return assumptions.
| Asset | Projected corpus | Total invested | Gain | Annual return |
|---|---|---|---|---|
| LIC MF Healthcare Fund-Direct Plan-GrowthFund 3Y annualised return · 5Y history unavailable | ₹12,83,374 | ₹7,32,612 | ₹5,50,762 | +21.95% |
| EPFIllustrative annual assumption | ₹8,95,132 | ₹7,32,612 | ₹1,62,520 | +8.25% |
| Residential propertyIllustrative annual assumption | ₹8,67,662 | ₹7,32,612 | ₹1,35,050 | +7.00% |
| PPFIllustrative annual assumption | ₹8,69,819 | ₹7,32,612 | ₹1,37,207 | +7.10% |
| Bank fixed depositIllustrative annual assumption | ₹8,56,981 | ₹7,32,612 | ₹1,24,369 | +6.50% |
| GoldIllustrative annual assumption | ₹8,67,662 | ₹7,32,612 | ₹1,35,050 | +7.00% |
| Savings accountIllustrative annual assumption | ₹7,86,827 | ₹7,32,612 | ₹54,215 | +3.00% |
Illustration only. Fund results use the available NAV-derived annualised return and can be negative. Reference rows are assumptions, not current quoted rates or guaranteed returns; property excludes transaction costs, taxes, and liquidity constraints. Mutual fund investments are subject to market risk.
Wealth multiple
₹1 became₹1.22
₹1 Lakh since launch₹1.22 Lakh
Fund age3.3 yrs
Fund information
Scheme code152024
ISININF397L01LK4
BenchmarkBSE Healthcare TRI
CategoryEquity Scheme - Sectoral/ Thematic
Expense ratio1.37%
Exit loadExit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days.
Minimum SIP₹200 SIP
Return comparison
104th / 932 in category| Period | Fund | Benchmark | Category avg |
|---|---|---|---|
| 1M | +189.59% | — | — |
| 3M | +12.21% | — | — |
| 6M | +27.86% | — | — |
| 1Y | +17.49% | — | +4.16% |
| 3Y | +21.95% | — | +12.54% |
| Since Launch | +21.62% | — | — |
Risk-adjusted performance
Every measure is expanded with a plain-language reading of the latest calculated value.
Sortino ratio
1.51Return earned while limiting downside risk.
Good
Good downside protection with strong returns.
Standard deviation
13.90%How much the fund’s returns fluctuate over time.
Moderate volatility
Returns can move up and down noticeably.
Beta
—How closely the fund moves with the market.
Unavailable
This measure needs sufficient fund and benchmark history to calculate.
Alpha
—Extra return generated above the benchmark.
Unavailable
This measure needs sufficient fund and benchmark history to calculate.
Treynor ratio
—Return earned for each unit of market risk taken.
Unavailable
This measure needs sufficient fund and benchmark history to calculate.
Calmar ratio
1.43How well the fund rewarded investors relative to its biggest decline.
Excellent
Excellent balance between returns and drawdowns.
Information ratio
—How consistently the fund outperformed its benchmark.
Unavailable
This measure needs sufficient fund and benchmark history to calculate.
Portfolio allocation
Latest disclosed portfolio mix
Asset allocation
Allocation data has not been disclosed.
Market cap allocation
Sector allocation
Equity exposure by sector
Top holdings
10 of 24 disclosed positions
| Holding | Sector | Instrument type | Weight |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.6874% |
| Divi's Laboratories Ltd | Healthcare | Equity | 9.4723% |
| Torrent Pharmaceuticals Ltd | Healthcare | Equity | 6.8873% |
| Apollo Hospitals Enterprise Ltd | Healthcare | Equity | 6.6191% |
| Neuland Laboratories Ltd | Healthcare | Equity | 5.5748% |
| Navin Fluorine International Ltd | Materials | Equity | 5.204% |
| Aurobindo Pharma Ltd | Healthcare | Equity | 5.024% |
| Zydus Lifesciences Ltd | Healthcare | Equity | 4.9036% |
| Aster DM Healthcare Ltd | Healthcare | Equity | 4.6722% |
| Fortis Healthcare Ltd | Healthcare | Equity | 4.1639% |
Fund management
SU
Sudhanshu Asthana
Since 2026 · Prior to joining LIC MF, he has worked with UTI Mutual Fund, Tamohara Investment Managers, Axis Mutual Fund, Barclays Wealth Management, SBI Mutaul Fund, Quantum Mutual Fund and BRICS Securities Ltd.
Mr. Asthana is a M.A (Economics) from Mumbai University and PGDM (Investment Management) from NMIMS.
DH
Dhaval Sangoi
Since 2026 · Prior to joining the LIC AMC, he was associated with HSBC Life Insurance Company Limited and Credit Suisse Business Analytics (India) Private Limited.
CFA, BMS, Narsee Monjee College of Commerce and Economics, Mumbai
Compare similar funds
No comparable category funds are available yet.
Summary
A very high-risk equity scheme - sectoral/ thematic fund. Ahead of its category average over 3Y by 9.4 points. Top 10 holdings make up 63% — a handful of stocks can swing returns sharply.
Strengths
- Ahead of its category average over 3Y by 9.4 points.
- Losses and swings stayed contained — worst fall -15.1%, volatility 13.9%.
- Ranks 104 of 932 in its category over 1 year.
Weaknesses
- Top 10 holdings make up 63% — a handful of stocks can swing returns sharply.
Ideal investor
- Needs a 5–7+ years horizon to ride out its very high risk level.
- Good fit for SIPs — spreading purchases smooths out 13.9% volatility.
Risk drivers
- Top 10 holdings = 63% of the portfolio.
- Healthcare makes up 92% — trouble in that sector hits the whole fund.